Nwk Group, Inc. Ionis Pharmaceuticals Inc Transaction History

Nwk Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $39,146 - $51,933	-825 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $3,513 - $4,578	75 Added 10.0%	825 $49,000
Q1 2020 May 12, 2020	BUY	$41.6 - $63.4 $4,160 - $6,340	100 Added 15.38%	750 $35,000
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $35,002 - $42,425	650 New	650 $39,000

398

122M

854K

464K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.68B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.